Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -100.87% is 94% below its 5-year average of -51.96%, near the low end of its 5-year range (-114.99%–-28.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.26% below its 12-month average of -83.88%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -100.87%.
RETURN ON INVESTED CAPITAL (ROIC)
-100.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-83.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-62.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-51.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-58.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-56.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-25.25%
CURRENT VS TTM AVG
-20.26%
CURRENT VS 3Y AVG
-61.44%
CURRENT VS 5Y AVG
-94.14%
CURRENT VS 10Y AVG
-72.55%
CURRENT VS 15Y AVG
-78.49%
CURRENT VS 20Y AVG
-299.49%
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 545 covered companies
CURRENT VS SECTOR MEDIAN
-219.02%
vs the sector median at left
DiaMedica Therapeutics Inc.
Market Cap
$457.20M
Return on Invested Capital (ROIC)
-100.87%
TTM Avg
-83.88%
3Y Avg
-62.48%
5Y Avg
-51.96%
Market Cap
$463.35M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$462.71M
Return on Invested Capital (ROIC)
-27.22%
TTM Avg
-25.30%
3Y Avg
-27.88%
5Y Avg
-30.72%
Market Cap
$460.98M
Return on Invested Capital (ROIC)
6.95%
TTM Avg
6.49%
3Y Avg
4.50%
5Y Avg
4.55%
Market Cap
$460.20M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$443.61M
Return on Invested Capital (ROIC)
-2.86%
TTM Avg
-34.72%
3Y Avg
-61.44%
5Y Avg
-57.77%
Market Cap
$472.58M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$434.84M
Return on Invested Capital (ROIC)
-40.25%
TTM Avg
-30.86%
3Y Avg
-64.07%
5Y Avg
-59.14%
Market Cap
$432.00M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | $457.20M | -100.87% | -83.88% | -62.48% | -51.96% |
| NRC Health (NRC)vs › | $463.35M | 8.75% | 20.32% | 26.86% | 29.17% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $462.71M | -27.22% | -25.30% | -27.88% | -30.72% |
| Kamada Ltd. (KMDA)vs › | $460.98M | 6.95% | 6.49% | 4.50% | 4.55% |
| NeoGenomics, Inc. (NEO)vs › | $460.20M | -5.29% | -5.58% | -6.88% | -5.95% |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | -2.86% | -34.72% | -61.44% | -57.77% |
| Cerus Corporation (CERS)vs › | $472.58M | -1.08% | -7.18% | -14.01% | -19.76% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | -40.25% | -30.86% | -64.07% | -59.14% |
| Editas Medicine, Inc. (EDIT)vs › | $432.00M | -48.61% | -80.33% | -62.04% | -50.84% |
| Arvinas, Inc. (ARVN)vs › | $478.75M | -2.19% | -24.50% | -28.59% | -24.45% |
ROIC
-100.9%
ROE
-97.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -100.87% |
| 2026-03-31 | -77.61% |
| 2025-12-31 | -61.16% |
| 2025-09-30 | -64.76% |
| 2025-06-30 | -114.99% |
| 2025-03-31 | -85.13% |
| 2024-12-31 | -65.15% |
| 2024-09-30 | -49.99% |
| 2024-06-30 | -41.68% |
| 2024-03-31 | -46.07% |
| 2023-12-31 | -41.40% |
| 2023-09-30 | -34.60% |
| 2023-06-30 | -28.89% |
| 2023-03-31 | -58.17% |
| 2022-12-31 | -43.35% |
| 2022-09-30 | -37.39% |
| 2022-06-30 | -35.95% |
| 2022-03-31 | -33.23% |
| 2021-12-31 | -30.99% |
| 2021-09-30 | -31.14% |
| 2021-06-30 | -71.66% |
| 2021-03-31 | -59.85% |
| 2020-12-31 | -48.72% |
| 2020-09-30 | -37.47% |
| 2020-06-30 | -92.32% |
| 2020-03-31 | -78.42% |
| 2019-12-31 | -148.72% |
| 2019-09-30 | -106.87% |
| 2019-06-30 | -78.21% |
| 2019-03-31 | -60.26% |
| 2018-12-31 | -32.55% |
| 2018-09-30 | -126.76% |
| 2018-06-30 | -56.02% |
| 2018-03-31 | 2.44% |
| 2012-09-30 | 96.75% |
| 2012-06-30 | 74.23% |
| 2012-03-31 | 69.36% |
| 2011-12-31 | 49.13% |
| 2011-09-30 | 43.02% |
| 2011-06-30 | 7.67% |
| 2011-03-31 | -22.38% |
| 2010-12-31 | -33.55% |
| 2010-09-30 | -23.54% |
| 2010-06-30 | -15.99% |
| 2010-03-31 | -188.85% |
| 2009-12-31 | -91.37% |
| 2009-09-30 | -3.56% |
| 2009-06-30 | 62.65% |
| 2008-12-31 | 76.96% |
| 2008-09-30 | 62.95% |
| 2008-06-30 | 64.69% |
| 2008-03-31 | 64.69% |
| 2007-12-31 | 45.22% |
| 2007-09-30 | 32.02% |
| 2007-06-30 | 27.46% |
| 2007-03-31 | 2.69% |
| 2006-12-31 | 33.77% |
| 2006-09-30 | 15.78% |
| 2005-12-31 | -29.47% |
